A detailed history of Gilder Gagnon Howe & CO LLC transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Gilder Gagnon Howe & CO LLC holds 1,622,883 shares of PHAT stock, worth $12.2 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
1,622,883
Previous 1,472,259 10.23%
Holding current value
$12.2 Million
Previous $15.2 Million 93.49%
% of portfolio
0.37%
Previous 0.2%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.25 - $19.5 $1.54 Million - $2.94 Million
150,624 Added 10.23%
1,622,883 $29.3 Million
Q2 2024

Aug 14, 2024

BUY
$8.97 - $12.05 $4.08 Million - $5.48 Million
454,642 Added 44.68%
1,472,259 $15.2 Million
Q1 2024

May 15, 2024

SELL
$6.21 - $11.05 $2.72 Million - $4.83 Million
-437,515 Reduced 30.07%
1,017,617 $10.8 Million
Q4 2023

Feb 14, 2024

BUY
$6.99 - $10.71 $1.01 Million - $1.55 Million
145,084 Added 11.07%
1,455,132 $13.3 Million
Q3 2023

Nov 14, 2023

BUY
$10.26 - $15.7 $2.56 Million - $3.92 Million
249,443 Added 23.52%
1,310,048 $13.6 Million
Q2 2023

Aug 14, 2023

BUY
$7.28 - $14.32 $3.69 Million - $7.26 Million
506,776 Added 91.5%
1,060,605 $15.2 Million
Q1 2023

May 15, 2023

BUY
$6.19 - $12.36 $12,392 - $24,744
2,002 Added 0.36%
553,829 $3.95 Million
Q4 2022

Feb 14, 2023

SELL
$9.18 - $11.53 $5,645 - $7,090
-615 Reduced 0.11%
551,827 $6.19 Million
Q3 2022

Nov 14, 2022

SELL
$6.46 - $12.11 $23,662 - $44,358
-3,663 Reduced 0.66%
552,442 $6.12 Million
Q2 2022

Aug 15, 2022

SELL
$6.2 - $15.5 $1,165 - $2,914
-188 Reduced 0.03%
556,105 $4.69 Million
Q1 2022

May 16, 2022

BUY
$11.55 - $20.06 $118,248 - $205,374
10,238 Added 1.87%
556,293 $7.57 Million
Q4 2021

Feb 14, 2022

SELL
$17.83 - $33.15 $74,618 - $138,732
-4,185 Reduced 0.76%
546,055 $10.7 Million
Q3 2021

Nov 15, 2021

BUY
$30.69 - $36.83 $114,105 - $136,933
3,718 Added 0.68%
550,240 $17.7 Million
Q2 2021

Aug 16, 2021

SELL
$32.66 - $39.87 $8.88 Million - $10.8 Million
-271,863 Reduced 33.22%
546,522 $18.5 Million
Q1 2021

May 17, 2021

BUY
$33.86 - $48.68 $27.7 Million - $39.8 Million
818,385 New
818,385 $30.7 Million

Others Institutions Holding PHAT

About Phathom Pharmaceuticals, Inc.


  • Ticker PHAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,175,200
  • Market Cap $294M
  • Description
  • Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...
More about PHAT
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.